112.145  2.915 (2.67%)		10-14 13:00
Open: 109.795 High: 112.39 Volume: 315,067		Pre. Close: 109.23 Low: 109.785 Market Cap: 974(M)

Short term
Mid term
Targets	6-month :	131.27	1-year :	153.32
Resists	First :	112.38	Second :	131.27
Pivot price	109.73
Supports	First :	108.97	Second :	106.86
MAs	MA(5) :	110.36	MA(20) :	110.04
	MA(100) :	109.16	MA(250) :	104.19
MACD	MACD :	-0.3	Signal :	-0.6
%K %D	K(14,3) :	72.4	D(3) :	65.5
RSI	RSI(14): 57.3
52-week	High :	117.61	Low :	88.79

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ PPH ] has closed below upper band by 3.0%. Bollinger Bands are 25.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	111.44 - 112.03	112.03 - 112.53
Low:	107.66 - 108.33	108.33 - 108.9
Close:	108.14 - 109.27	109.27 - 110.22

VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Sun, 11 Oct 2026
Which Healthcare ETF Is the Better Buy: Simplify’s Active PINK or VanEck’s Pharma-Focused PPH? - The Motley Fool

Mon, 05 Oct 2026
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance Singapore

Fri, 02 Oct 2026
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP - The Globe and Mail

Fri, 02 Oct 2026
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP - The Motley Fool

Tue, 15 Sep 2026
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits? - The Motley Fool

Fri, 11 Sep 2026
Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs. Invesco Healthcare ETF Compared. - The Motley Fool

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.